Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide vs Terlipressin for Prevention of Acute Kidney Injury in Cirrhotic Patients With Gastroesophageal Variceal Bleeding
TCTR20250319016Phase 1Enrolling by invitation
- Sponsor
- Faculty of Medicine, Chiang Mai University
- Start
- Apr 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1 trial of octreotide and terlipressin in Cirrhosis, Gastroesophageal varices (GEV) and gastrointestinal bleeding (2 arms), sponsored by Faculty of Medicine, Chiang Mai University. Started Apr 2025; status: enrolling by invitation.
02
Drugs
octreotideterlipressin
03
Conditions
CirrhosisGastroesophageal varices (GEV)gastrointestinal bleeding
Beyond the preview
Go deeper on TCTR20250319016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250319016.